ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
PRSO
Peraso Inc.
There isn't enough reported data to score PRSO yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PRSO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
PRSO's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
PRSO PE Valuation
PRSO has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PRSO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect PRSO's losses to shrink, with revenue growing.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
PRSO has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus PRSO down 104%.
PRSO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$16.34 | +$26.86 |
| Q2 2024 | -$16.16 | +$34.24 |
| Q1 2024 | -$21.08 | +$35.72 |
| Q4 2023 | -$26.01 | +$38.39 |
| Q3 2023 | -$43.20 | +$39.60 |
| Q2 2023 | -$50.40 | +$32.40 |
| Q1 2023 | -$56.80 | +$20.00 |
| Q4 2022 | -$64.40 | +$10.00 |
PRSO lost $0.64 per share over the past year, a smaller loss than the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over PRSO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
PRSO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3M | -41% |
| Q1 2026 | $963K | -75% |
| Q4 2025 | $2.9M | -22% |
| Q3 2025 | $3.2M | -16% |
| Q2 2025 | $2.2M | -48% |
| Q1 2025 | $3.9M | +37% |
| Q4 2024 | $3.7M | +101% |
| Q3 2024 | $3.8M | -14% |
PRSO's revenue has slid since its 2023 peak: $1M last quarter, down 41% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -171% | -91 points |
| Q1 2026 | -258% | -245 points |
| Q4 2025 | -45% | -0.3 points |
| Q3 2025 | -37% | +34 points |
| Q2 2025 | -80% | +26 points |
| Q1 2025 | -13% | +116 points |
| Q4 2024 | -44% | +405 points |
| Q3 2024 | -70% | +9.2 points |
PRSO has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
PRSO has the stronger cash trend. Its trailing FCF is up 19% versus its history, compared with ASTS at down 363%.
PRSO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$2.5M | -$1.6M |
| Q4 2023 | $936K | +$3.9M |
| Q3 2023 | -$2.1M | +$37K |
| Q2 2023 | -$2.2M | +$3.9M |
| Q1 2023 | -$1.5M | +$4.3M |
| Q4 2022 | -$3M | +$4.5M |
| Q3 2022 | -$2.1M | -$267K |
| Q2 2022 | -$6.1M | -$4.3M |
PRSO has burned cash in almost every quarter: −$7M over the past year, against −$4M the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over PRSO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
PRSO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +60% | +4.4M shares |
| 1 year | +318% | +8.8M shares |
| 3 years | +2047% | +11.1M shares |
| 5 years | +21356% | +11.6M shares |
PRSO has 12M diluted shares, up 318% from a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PRSO Net Leverage
PRSO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
PRSO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 10.9 | Oversold |
PRSO's weekly RSI is 33 (neutral) and its Stochastic is 11 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
PRSO PE vs Technology Sector
PRSO has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over PRSO on trend strength, trading above more of its moving averages.
PRSO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.40 | 7.5% below |
| 20 week MA | $0.56 | 34% below |
| 50 week MA | $0.84 | 56% below |
| 100 week MA | $0.93 | 60% below |
| 200 week MA | $5.32 | 93% below |
PRSO is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over PRSO on returns for 2026, with the stronger performance.
PRSO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $67.2 | $79.2 | +18% |
| 2021 | $79.2 | $201.2 | +154% |
| 2022 | $201.2 | $34.0 | -83% |
| 2023 | $34.0 | $11.2 | -67% |
| 2024 | $11.2 | $1.31 | -88% |
| 2025 | $1.31 | $1.01 | -23% |
| 2026 YTD | $1.01 | $0.37 | -63% |
PRSO has finished four years in a row lower, and it's down 63% so far in 2026.